Cited by 313Dementia and Cognitive Impairment ResearchDiabetes Treatment and ManagementDiabetes Management and Research

Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia

Open access
Yaffe, Kristine, Falvey, Cherie, Hamilton, Nathan, Schwartz, Ann V., Simonsick, Eleanor M., Satterfield, Suzanne, Cauley, Jane A., Rosano, Caterina +3 more·2012·Archives of Neurology

Abstract

OBJECTIVES: To determine if prevalent and incident diabetes mellitus (DM) increase risk of cognitive decline and if, among elderly adults with DM, poor glucose control is related to worse cognitive performance. DESIGN Prospective cohort study. SETTING: Health, Aging, and Body Composition Study at 2 community clinics. PARTICIPANTS: A total of 3069 elderly adults (mean age, 74.2 years; 42% black; 52% female). MAIN OUTCOME MEASURES: Participants completed the Modified Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST) at baseline and selected intervals over 10 years. Diabetes mellitus status was determined at baseline and during follow-up visits. Glycosylated hemoglobin A1c level was measured at years 1 (baseline), 4, 6, and 10 from fasting whole blood. RESULTS: At baseline, 717 participants (23.4%) had prevalent DM and 2352 (76.6%) were without DM, 159 of whom developed incident DM during follow-up. Participants with prevalent DM had lower baseline test scores than participants without DM (3MS: 88.8 vs 90.9; DSST: 32.5 vs 36.3, respectively; t = 6.09; P = .001 for both tests). Results from mixed-effects models showed a similar pattern for 9-year decline (3MS: -6.0- vs -4.5-point decline; t = 2.66; P = .008; DSST: -7.9- vs -5.7-point decline; t = 3.69; P = .001, respectively). Participants with incident DM tended to have baseline and 9-year decline scores between the other 2 groups but were not statistically different from the group without DM. Multivariate adjustment for demographics and medical comorbidities produced similar results. Among participants with prevalent DM, glycosylated hemoglobin A1c level was associated with lower average mean cognitive scores (3MS: F = 8.2; P for overall = .003; DSST: F = 3.4; P for overall = .04), even after multivariate adjustment. CONCLUSION: Among well-functioning older adults, DM and poor glucose control among those with DM are associated with worse cognitive function and greater decline. This suggests that severity of DM may contribute to accelerated cognitive aging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/archneurol.2012.1117

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Poor glycemic management is associated with a decline in cognitive function.

    “Poor glycemic management is associated with a decline in cognitive function (15,16), and longer duration of diabetes is associated with worsening cognitive function.”
  • Longer duration of diabetes is associated with worsening cognitive function.

    “Poor glycemic management is associated with a decline in cognitive function (15,16), and longer duration of diabetes is associated with worsening cognitive function.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 24

  1. [2]Biessels GJ Staekenborg S Brunner E Brayne C Scheltens P Risk of dementia in diabetes mellitus: a systematic review Lancet Neurol 2006 5 64 74 16361024
  2. [4]Yaffe K Blackwell TL Kanaya AM Davidowitz N Barrett-Connor E Krueger K Diabetes, impaired fasting glucose, and development of cognitive impairment in older women Neurology 2004 63 658 663 15326238
  3. [6]Ryan CM Geckle M Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab Res Rev 2000 16 308 315 11025555
  4. [8]Biessels GJ Deary IJ Ryan CM Cognition and diabetes:a lifespan perspective Lancet Neurol 2008 7 184 190 18207116
  5. [9]Cukierman-Yaffe T Gerstein HC Williamson JD Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors Diabetes Care 2009 32 221 226 19171735 PMC2628683
  6. [10]Yaffe K Blackwell T Whitmer RA Krueger K Barrett-Connor E Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women J Nutr Health Aging 2006 10 293 295 16886099
  7. [11]Nguyen HT Grzywacz JG Arcury TA Linking glycemic control and executive function in rural older adults with diabetes mellitus J Am Geriatr Soc 2010 58 1123 1127 20722846 PMC3641527
  8. [13]Christman AL Matsushita K Gottesman RF Glycated haemoglobin and cognitive decline: the Atherosclerosis Risks in Communities (ARIC) study Diabetologia 2011 PMC3326598 21360189
  9. [15]Teng E Chui H The Modified Mini-Mental State (3MS) examination J Clin Psychiatry 1987 48 314 318 3611032
  10. [16]Wechsler D Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) 1997 Third ed San Antonio The Psychological Corporation
  11. [18]Livak K SNP genotyping by the 5'-nuclease reaction Methods Mol Biol 2003 212 129 147 12491907
  12. [19]Ruis C Biessels GJ Gorter KJ Van Den Donk M Kappelle LJ Rutten GEHM Cognition in the Early Stages of Type 2 Diabetes Diabetes Care 2009 32 1261 1265 19366968 PMC2699741
  13. [20]Nooyens A Baan C Spijkerman A Verschuren W Type 2 Diabetes and Cognitive Decline in Middle-Aged Men and Women: The Doetinchem Cohort Study Diabetes Care 2010 33 1964 1969 20519662 PMC2928345
  14. [21]Roberts RO Geda YE Knopman DS Association of duration and severity of diabetes mellitus with mild cognitive impairment Arch Neurol 2008 65 1066 1073 18695056 PMC2630223
  15. [22]Cox DJ Kovatchev BP Gonder-Frederick LA Relationships between hyperglycemia and cognitive performance among adults with type1 and type 2 diabetes Diabetes Care 2005 28 71 77 15616236
  16. [23]The American Diabetes Association Executive Summary: Standards of Medical Care in Diabetes-2012 Diabetes Care 2012 35 s4 s10 22187471 PMC3632178
  17. [24]Launer L Miller ME Williamson JD Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label study Lancet Neurol 2011 10 969 977 21958949 PMC3333485
  18. [25]Vlassara H Palace MR Diabetes and advanced glycation endproducts J Intern Med 2002 251 87 101 11905595
  19. [27]Launer LJ Demonstrating the case that AD is a vascular disease: epidemiologic evidence Ageing Res Rev 2002 1 61 77 12039449
  20. [28]Whitmer RA Karter AJ Yaffe K Quesenberry CPJ Selby JV Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus JAMA 2009 301 1565 1572 19366776 PMC2782622
  21. [29]Strachan MW Reynolds RM Marioni RE Price JF Cognitive function, dementia and type 2 diabetes mellitus in the elderly Nat Rev Endocrinol 2011 7 108 114 21263438
  22. [30]Yaffe K Ackerson L Kurella Tamura M Chronic kidney disease and cognitive function in older adults: findings from the Chronic Renal Insufficiency Cohort Cognitive Study Journal of the American Geriatrics Society 2010 58 338 345 20374407 PMC2852884
  23. [31]Knopman D Boland LL Mosley T Cardiovascular risk factors and cognitve decline in middle-aged adults Neurology 2001 56 42 48 11148234
  24. [32]Tan ZS Beiser AS Fox CS Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: The Framingham offspring study Diabetes Care 2011 34 1766 1770 21680719 PMC3142014

Cited by

Sorted by citations

Authors
Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A. V., Simonsick, E. M., Satterfield, S., Cauley, J. A., Rosano, C., Launer, L. J., Strotmeyer, E. S., & Harris, T. B.
Affiliations
  • University of California, San Francisco (US)
  • University of Tennessee Health Science Center (US)
  • National Institutes of Health (US)
  • San Francisco VA Medical Center (US)
  • University of Pittsburgh (US)
Corresponding author
Yaffe, Kristine
Venue
Archives of Neurology
Published
2012-09-01
Volume
69
Issue
9
Pages
1170-5
ISSN
0003-9942 (ISSN-L)
OpenAlex
W2101868057
Cited by
313
References
6
Citations by year
2026: 11 · 2025: 12 · 2024: 13 · 2023: 16 · 2022: 12 · 2021: 28 · 2020: 22 · 2019: 27 · 2018: 31 · 2017: 18 · 2016: 30 · 2015: 31 · 2014: 36 · 2013: 22 · 2012: 3
FWCI
21.02
Type
journal article
Language
en
Open access
Locations
  • Archives of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • U.S. Department of Defense
  • American Health Assistance Foundation
  • Amgen
  • Pfizer
  • GlaxoSmithKline
  • National Institutes of Health (N01-AG-6-2103, n01ag062101-007, n01ag062103-006, N01‐AG‐6‐2106, n01ag062106-007, N01-AG-6-2101)
  • National Institute on Aging (N01‐AG‐6–2101, R01‐NR012459, R01AG028050, K24AG031155, N01 AG062106, N01AG62106, N01-AG-62103, N01 AG062103, N01 AG062101)
  • National Institute of Mental Health (N01-AG-6-2101, N01-AG-6-2106, R01-NR012459, R01-AG028050)
  • National Institute of Nursing Research (N01-AG-6–2101, N01-AG-6-2103, N01-AG-6–2106, R01NR012459)
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetes mellitus, glycemic control, cognitive decline, older adults, glycosylated hemoglobin A1c, new-onset diabetes, cognitive aging, cognitive function, diabetes severity, Health, Aging, and Body Composition Study, community-dwelling older adults, sex differences, racial differences, socioeconomic status, physical activity, body mass index, alcohol consumption
MeSH terms
Aged, Aged, 80 and over, Aging, Blood Glucose, Cognition, Cognition Disorders, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Prospective Studies, Risk, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review